CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a new optical technology for real-time monitoring of blood flow and oxygen levels in the brain during acute ischemic stroke treatment. The goal is to enhance patient outcomes by individualizing treatment based on precise hemodynamic data.
Ischemic stroke is the leading cause of morbidity and long term disability in Europe and United States and one of the leading causes of death.
The intravenous recombinant tissue-type plasminogen activator (rtPA) is the premier drug indicated for treatment of acute ischemic stroke.
Current guidelines call for its administration within the first ~three hours of the stroke onset (now being extended to 4.5 hours due to positive results of ECASS III study).
However, despite its success, about 50% of…
FUNDACIO INSTITUT DE CIENCIES FOTONIQUES
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
